Mitochondrial 4-HNE derived from MAO-A promotes mitoCa


Journal

Cell death and differentiation
ISSN: 1476-5403
Titre abrégé: Cell Death Differ
Pays: England
ID NLM: 9437445

Informations de publication

Date de publication:
06 2020
Historique:
received: 31 05 2019
accepted: 25 11 2019
revised: 25 11 2019
pubmed: 11 12 2019
medline: 9 9 2021
entrez: 11 12 2019
Statut: ppublish

Résumé

Chronic remodeling postmyocardial infarction consists in various maladaptive changes including interstitial fibrosis, cardiomyocyte death and mitochondrial dysfunction that lead to heart failure (HF). Reactive aldehydes such as 4-hydroxynonenal (4-HNE) are critical mediators of mitochondrial dysfunction but the sources of mitochondrial 4-HNE in cardiac diseases together with its mechanisms of action remain poorly understood. Here, we evaluated whether the mitochondrial enzyme monoamine oxidase-A (MAO-A), which generates H

Identifiants

pubmed: 31819159
doi: 10.1038/s41418-019-0470-y
pii: 10.1038/s41418-019-0470-y
pmc: PMC7244724
doi:

Substances chimiques

Aldehydes 0
Monoamine Oxidase EC 1.4.3.4
monoamine oxidase A, human EC 1.4.3.4.
4-hydroxy-2-nonenal K1CVM13F96
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1907-1923

Références

Brown DA, Perry JB, Allen ME, Sabbah HN, Stauffer BL, Shaikh SR, et al. Mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. 2017;14:238–50.
doi: 10.1038/nrcardio.2016.203
Rizzuto R, De Stefani D, Raffaello A, Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Bio. 2012;13:566–78.
doi: 10.1038/nrm3412
Bertero E, Maack C. Calcium signaling and reactive oxygen species in mitochondria. Circulation Res. 2018;122:1460–78.
doi: 10.1161/CIRCRESAHA.118.310082
Luongo TS, Lambert JP, Gross P, Nwokedi M, Lombardi AA, Shanmughapriya S, et al. The mitochondrial Na
doi: 10.1038/nature22082
Santulli G, Xie WJ, Reiken SR, Marks AR. Mitochondrial calcium overload is a key determinant in heart failure. Proc Natl Acad Sci USA. 2015;112:11389–94.
doi: 10.1073/pnas.1513047112
Kornfeld OS, Hwang S, Disatnik M-H, Chen C-H, Qvit N, Mochly-Rosen D. Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases. Circulation Res. 2015;116:1783–99.
doi: 10.1161/CIRCRESAHA.116.305432
Gueraud F. 4-Hydroxynonenal metabolites and adducts in pre-carcinogenic conditions and cancer. Free Radic Bio Med. 2017;111:196–208.
doi: 10.1016/j.freeradbiomed.2016.12.025
Mak S, Lehotay DC, Yazdanpanah M, Azevedo ER, Liu PP, Newton GE. Unsaturated aldehydes including 4-OH-nonenal are elevated in patients with congestive heart failure. J Card Fail. 2000;6:108–14.
doi: 10.1016/S1071-9164(00)90012-5
Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science. 2008;321:1493–5.
doi: 10.1126/science.1158554
Gomes KM, Campos JC, Bechara LR, Queliconi B, Lima VM, Disatnik MH, et al. Aldehyde dehydrogenase 2 activation in heart failure restores mitochondrial function and improves ventricular function and remodelling. Cardiovasc Res. 2014;103:498–508.
doi: 10.1093/cvr/cvu125
Kaludercic N, Mialet-Perez J, Paolocci N, Parini A, Di Lisa F. Monoamine oxidases as sources of oxidants in the heart. J Mol Cell Cardiol. 2014;73:34–42.
doi: 10.1016/j.yjmcc.2013.12.032
Villeneuve C, Guilbeau-Frugier C, Sicard P, Lairez O, Ordener C, Duparc T, et al. p53-PGC-1alpha pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice. Antioxid Redox Signal. 2013;18:5–18.
doi: 10.1089/ars.2011.4373
Liao C-P, Lin T-P, Li P-C, Geary LA, Chen K, Vaikari VP, et al. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate. Oncogene. 2018;37:5175–90.
doi: 10.1038/s41388-018-0325-x
Abadie S, Jardet C, Colombelli J, Chaput B, David A, Grolleau JL, et al. 3D imaging of cleared human skin biopsies using light-sheet microscopy: a new way to visualize in-depth skin structure. Ski Res Technol. 2018;24:294–303.
doi: 10.1111/srt.12429
Morel E, Marcantoni A, Gastineau M, Birkedal R, Rochais F, Garnier A, et al. cAMP-binding protein Epac induces cardiomyocyte hypertrophy. Circulation Res. 2005;97:1296–304.
doi: 10.1161/01.RES.0000194325.31359.86
Fazal L, Laudette M, Paula-Gomes S, Pons S, Conte C, Tortosa F, et al. Multifunctional mitochondrial Epac1 controls myocardial cell death. Circ Res. 2017;120:645–57.
doi: 10.1161/CIRCRESAHA.116.309859
Liu W, Porter NA, Schneider C, Brash AR, Yin HY. Formation of 4-hydroxynonenal from cardiolipin oxidation: Intramolecular peroxyl radical addition and decomposition. Free Radic Bio Med. 2011;50:166–78.
doi: 10.1016/j.freeradbiomed.2010.10.709
Giorgi C, Missiroli S, Patergnani S, Duszynski J, Wieckowski MR, Pinton P. Mitochondria-associated membranes: composition, molecular mechanisms, and physiopathological implications. Antioxid Redox Sign. 2015;22:995–1019.
doi: 10.1089/ars.2014.6223
Patron M, Checchetto V, Raffaello A, Teardo E, Reane DV, Mantoan M, et al. MICU1 and MICU2 finely tune the mitochondrial Ca2+ uniporter by exerting opposite effects on MCU activity. Mol Cell. 2014;53:726–37.
doi: 10.1016/j.molcel.2014.01.013
Tomar D, Dong Z, Shanmughapriya S, Koch DA, Thomas T, Hoffman NE, et al. MCUR1 Is a scaffold factor for the MCU complex function and promotes mitochondrial bioenergetics. Cell Rep. 2016;15:1673–85.
doi: 10.1016/j.celrep.2016.04.050
Wang Y, Nguyen NX, She J, Zeng W, Yang Y, Bai XC, et al. Structural mechanism of EMRE-dependent gating of the human mitochondrial calcium uniporter. Cell. 2019;177:1252–61 e13.
doi: 10.1016/j.cell.2019.03.050
Manni ME, Rigacci S, Borchi E, Bargelli V, Miceli C, Giordano C, et al. Monoamine oxidase Is overactivated in left and right ventricles from ischemic hearts: an intriguing therapeutic target. Oxid Med Cell Longev. 2016;2016:4375418.
doi: 10.1155/2016/4375418
Pchejetski D, Kunduzova O, Dayon A, Calise D, Seguelas MH, Leducq N, et al. Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis. Circ Res. 2007;100:41–9.
doi: 10.1161/01.RES.0000253900.66640.34
Kaludercic N, Takimoto E, Nagayama T, Feng N, Lai EW, Bedja D, et al. Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ Res. 2010;106:193–202.
doi: 10.1161/CIRCRESAHA.109.198366
Santin Y, Sicard P, Vigneron F, Guilbeau-Frugier C, Dutaur M, Lairez O, et al. Oxidative stress by monoamine oxidase-A impairs transcription factor EB activation and autophagosome clearance, leading to cardiomyocyte necrosis and heart failure. Antioxid Redox Signal. 2016;25:10–27.
doi: 10.1089/ars.2015.6522
Kaludercic N, Carpi A, Nagayama T, Sivakumaran V, Zhu G, Lai EW, et al. Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts. Antioxid Redox Signal. 2014;20:267–80.
doi: 10.1089/ars.2012.4616
Xiao MQ, Zhong HQ, Xia L, Tao YZ, Yin HY. Pathophysiology of mitochondrial lipid oxidation: role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic Bio Med. 2017;111:316–27.
doi: 10.1016/j.freeradbiomed.2017.04.363
Sparagna GC, Chicco AJ, Murphy RC, Bristow MR, Johnson CA, Rees ML, et al. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J lipid Res. 2007;48:1559–70.
doi: 10.1194/jlr.M600551-JLR200
Zhao Y, Miriyala S, Miao L, Mitov M, Schnell D, Dhar SK, et al. Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment. Free Radic Bio Med. 2014;72:55–65.
doi: 10.1016/j.freeradbiomed.2014.03.001
Paillard M, Tubbs E, Thiebaut PA, Gomez L, Fauconnier J, Teixeira G, et al. Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia-reoxygenation injury. Circulation. 2013;128:1555–65.
doi: 10.1161/CIRCULATIONAHA.113.001225
Dodson M, Wani WY, Redmann M, Benavides GA, Johnson MS, Ouyang X, et al. Regulation of autophagy, mitochondrial dynamics, and cellular bioenergetics by 4-hydroxynonenal in primary neurons. Autophagy. 2017;13:1828–40.
doi: 10.1080/15548627.2017.1356948
Dong Z, Shanmughapriya S, Tomar D, Siddiqui N, Lynch S, Nemani N, et al. Mitochondrial Ca(2+) Uniporter Is a Mitochondrial Luminal Redox Sensor that Augments MCU Channel Activity. Mol Cell. 2017;65:1014–28 e7.
doi: 10.1016/j.molcel.2017.01.032
Holmstrom KM, Pan X, Liu JC, Menazza S, Liu J, Nguyen TT, et al. Assessment of cardiac function in mice lacking the mitochondrial calcium uniporter. J Mol Cell Cardiol. 2015;85:178–82.
doi: 10.1016/j.yjmcc.2015.05.022
Pan X, Liu J, Nguyen T, Liu C, Sun J, Teng Y, et al. The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter. Nat Cell Biol. 2013;15:1464–72.
doi: 10.1038/ncb2868
Luongo TS, Lambert JP, Yuan A, Zhang X, Gross P, Song J, et al. The Mitochondrial Calcium Uniporter Matches Energetic Supply with Cardiac Workload during Stress and Modulates Permeability Transition. Cell Rep. 2015;12:23–34.
doi: 10.1016/j.celrep.2015.06.017
Yu Z, Chen R, Li M, Yu Y, Liang Y, Han F, et al. Mitochondrial calcium uniporter inhibition provides cardioprotection in pressure overload-induced heart failure through autophagy enhancement. Int J Cardiol. 2018;271:161–8.
doi: 10.1016/j.ijcard.2018.05.054

Auteurs

Yohan Santin (Y)

Institute of Metabolic and Cardiovascular Diseases (I2MC), INSERM, Université de Toulouse, Toulouse, France.

Loubina Fazal (L)

Institute of Metabolic and Cardiovascular Diseases (I2MC), INSERM, Université de Toulouse, Toulouse, France.

Yannis Sainte-Marie (Y)

Institute of Metabolic and Cardiovascular Diseases (I2MC), INSERM, Université de Toulouse, Toulouse, France.

Pierre Sicard (P)

Institute of Metabolic and Cardiovascular Diseases (I2MC), INSERM, Université de Toulouse, Toulouse, France.
INSERM, CNRS, Université de Montpellier, PHYMEDEXP, Montpellier, France.

Damien Maggiorani (D)

Institute of Metabolic and Cardiovascular Diseases (I2MC), INSERM, Université de Toulouse, Toulouse, France.

Florence Tortosa (F)

Institute of Metabolic and Cardiovascular Diseases (I2MC), INSERM, Université de Toulouse, Toulouse, France.

Yasemin Yücel Yücel (YY)

Department of Biochemistry, School of Pharmacy, Altinbas University, Istanbul, Turkey.

Lise Teyssedre (L)

ITAV, CNRS, Université de Toulouse, Toulouse, France.

Jacques Rouquette (J)

ITAV, CNRS, Université de Toulouse, Toulouse, France.

Marlene Marcellin (M)

Institut de Pharmacologie et de Biologie Structurale, CNRS, Université de Toulouse, UPS, Toulouse, France.

Cécile Vindis (C)

Institute of Metabolic and Cardiovascular Diseases (I2MC), INSERM, Université de Toulouse, Toulouse, France.

Jean C Shih (JC)

University of Southern California, Los Angeles, CA, USA.

Olivier Lairez (O)

Institute of Metabolic and Cardiovascular Diseases (I2MC), INSERM, Université de Toulouse, Toulouse, France.

Odile Burlet-Schiltz (O)

Institut de Pharmacologie et de Biologie Structurale, CNRS, Université de Toulouse, UPS, Toulouse, France.

Angelo Parini (A)

Institute of Metabolic and Cardiovascular Diseases (I2MC), INSERM, Université de Toulouse, Toulouse, France. angelo.parini@inserm.fr.

Frank Lezoualc'h (F)

Institute of Metabolic and Cardiovascular Diseases (I2MC), INSERM, Université de Toulouse, Toulouse, France.

Jeanne Mialet-Perez (J)

Institute of Metabolic and Cardiovascular Diseases (I2MC), INSERM, Université de Toulouse, Toulouse, France. jeanne.perez@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH